Risperidone plasma level, and its correlation with CYP2D6 gene polymorphism, clinical response and side effects in chronic schizophrenia patients

被引：0
|
作者：
Xiaoyi Wang
Jing Huang
Jianjun Lu
Xuemei Li
Hui Tang
Ping Shao
机构：
[1] The Second Xiangya Hospital of Central South University,Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders
[2] The Third People’s Hospital of Jiangyin City,undefined
[3] People’s Hospital of Dali Prefecture,undefined
来源：
BMC Psychiatry | / 24卷
关键词：
Risperidone; Chronic schizophrenia; Plasma concentration; polymorphism; Effect; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine
    Azuma, Junichi
    Hasunuma, Tomoko
    Kubo, Masanori
    Miyatake, Masaya
    Koue, Toshiko
    Higashi, Koushi
    Fujiwara, Tsutomu
    Kitahara, Sachiko
    Katano, Tamiki
    Hara, Sumiko
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (01) : 29 - 37
  • [42] Impact of CYP2D6*2A, CYP2D6*4 and CYP3A5*3 genetic polymorphisms on Bisoprolol peak concentration and clinical response in acute coronary syndrome patients
    Okda, Sherouk M.
    El-Bassiouny, Noha A.
    El Amrawy, Ahmed Mahmoud
    Salahuddin, Ahmad
    Elonsy, Sohila M.
    Kassem, Amira B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (10) : 2539 - 2553
  • [43] The cytochrome P450 2D6 (CYP2D6) gene polymorphism among breast and head and neck cancer patients
    Topic, E
    Stefanovic, M
    Ivanisevic, AM
    Petrinovic, R
    Curcic, I
    CLINICA CHIMICA ACTA, 2000, 296 (1-2) : 101 - 109
  • [44] Effects of CYP2D6*4 Polymorphism in the Developmet of Ploygenetic Diseases in Chechen Poplulation
    Bisultanova, Z. I.
    Molochaeva, L. G.
    Dzhambetova, P. M.
    Atsayeva, Maret M.
    Machigov, Elbek A.
    Plieva, Aishet M.
    PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ENGINEERING AND EARTH SCIENCES: APPLIED AND FUNDAMENTAL RESEARCH (ISEES 2018), 2018, 177 : 133 - 136
  • [45] CYP2D6 Genotype Predicts Antipsychotic Side Effects in Schizophrenia Inpatients: A Retrospective Matched Case-Control Study
    Kobylecki, Camilla J.
    Jakobsen, Klaus D.
    Hansen, Thomas
    Jakobsen, Ida V.
    Rasmussen, Henrik B.
    Werge, Thomas
    NEUROPSYCHOBIOLOGY, 2009, 59 (04) : 222 - 226
  • [46] CYP2D6 genotyping for psychiatric patients treated with risperidone: considerations for cost-effectiveness studies
    Rodriguez-Antona, Cristina
    Gurwitz, David
    de Leon, Jose
    Llerena, Adrian
    Kirchheiner, Julia
    Gutierrez de Mesa, Emma
    Ibarreta, Dolores
    PHARMACOGENOMICS, 2009, 10 (04) : 685 - 699
  • [47] Risperidone plasma concentrations are associated with hyperprolactinemia in autism spectrum disorder children: The impact of CYP2D6 polymorphisms
    Chamnanphon, Monpat
    Vanwong, Natchaya
    Prommas, Santirhat
    Koomdee, Napatrupron
    Sukprasong, Rattanaporn
    Rachanakul, Jiratha
    Nuntharadthanaphong, Nutthan
    Hongkaew, Yaowaluck
    John, Shobana
    Ngamsamut, Nattawat
    Nuntamool, Nopphadol
    Limsila, Penkhae
    Sukasem, Chonlaphat
    RESEARCH IN AUTISM SPECTRUM DISORDERS, 2022, 96
  • [48] The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients
    Xing, Qinghe
    Qian, Xueqing
    Li, Huafang
    Wong, Shiming
    Wu, Shengnan
    Feng, Guoyin
    Duan, Shiwei
    Xu, Mingqing
    Gao, Rui
    Qin, Wei
    Gao, Jianjun
    Meng, Junwei
    He, Lin
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2007, 10 (05) : 631 - 637
  • [49] Haloperidol plasma concentration in Japanese psychiatric subjects with gene duplication of CYP2D6
    Ohnuma, T
    Shibata, N
    Matsubara, Y
    Arai, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (03) : 315 - 320
  • [50] Simultaneous quantification of the CYP2D6 substrate yohimbine, its metabolite 11-OH-yohimbine, and the CYP2D6 inhibitor paroxetine in human plasma
    Vay, Manuela
    Skopp, Gisela
    Mikus, Gerd
    Burhenne, Juergen
    ANALYTICAL METHODS, 2019, 11 (47) : 5976 - 5983
12345